Evidence map›Paper›PMID 37638323›Full record

ArticleFrontiers in neuroscience2023

ACE2 overexpression in corticotropin-releasing-hormone cells offers protection against pulmonary hypertension.

Aline C Oliveira, Marianthi M Karas, Matthew Alves, Jacky He, Annette D de Kloet, Eric G Krause, Elaine M Richards, Andrew J Bryant, Mohan K Raizada

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. [Mechanisms by Which Paraventricular Hypothalamic Nucleus Participates in the Acupuncture Treatment of Diseases].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2025
    Review
  3. Review
  4. Article
  5. Mesenchymal stem cell therapy for pulmonary hypertension: an update.Frontiers in bioengineering and biotechnology · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Aline C OliveiraDivision of Pulmonary, Critical Care and Sleep Medicine, College of Medicine, University of Florida, Gainesville, FL, United States.
Marianthi M KarasDivision of Pulmonary, Critical Care and Sleep Medicine, College of Medicine, University of Florida, Gainesville, FL, United States.
Matthew AlvesDivision of Pulmonary, Critical Care and Sleep Medicine, College of Medicine, University of Florida, Gainesville, FL, United States.
Jacky HeEvelyn F. and William L. McKnight Brain Institute, University of Florida, Gainesville, FL, United States.
Annette D de KloetDepartment of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, FL, United States.
Eric G KrauseEvelyn F. and William L. McKnight Brain Institute, University of Florida, Gainesville, FL, United States.
Elaine M RichardsDepartment of Physiology and Aging, College of Medicine, University of Florida, Gainesville, FL, United States.
Andrew J BryantDivision of Pulmonary, Critical Care and Sleep Medicine, College of Medicine, University of Florida, Gainesville, FL, United States.
Mohan K RaizadaDepartment of Physiology and Aging, College of Medicine, University of Florida, Gainesville, FL, United States.
University of Florida · US

Funding

Role of ADAM17 in MDSC-Mediated Development of Pulmonary HypertensionR01HL142887 · NHLBI · UNIVERSITY OF FLORIDA · PI BRYANT, ANDREW JUSTIN · 2020 to 2024
$1.9M
Role of CXCR2-mediated cell trafficking in pulmonary vascular remodelingR01HL142776 · NHLBI · UNIVERSITY OF FLORIDA · PI BRYANT, ANDREW JUSTIN · 2019 to 2023
$1.9M
NHLBI NIH HHS R01 HL142776NHLBI NIH HHS R01 HL142887
6 · The paper itself

Abstract

Background: Pulmonary hypertension (PH), characterized by elevated pulmonary pressure and right heart failure, is a systemic disease involving inappropriate sympathetic activation and an impaired gut-brain-lung axis. Global overexpression of angiotensin converting enzyme 2 (ACE2), a cardiopulmonary protective enzyme of the renin-angiotensin system, attenuates PH induced by chronic hypoxia. Neurons within the paraventricular nucleus of the hypothalamus (PVN) that synthesize corticotropin-releasing hormone (CRH) are activated by stressors, like hypoxia, and this activation augments sympathetic outflow to cardiovascular tissues. These data coupled with our observations that ACE2 overexpression in CRH cells (CRH-ACE2KI mice) decreases anxiety-like behavior via suppression of hypothalamic-pituitary-adrenal (HPA) axis activity by decreasing CRH synthesis, led us to hypothesize that selective ACE2 overexpression in CRH neurons would protect against hypoxia-induced PH. Methods: CRH-ACE2KI and WT male and female mice were exposed to chronic hypoxia (10%O2) or normoxia (21%O2) for 4 weeks in a ventilated chamber with continuous monitoring of oxygen and carbon dioxide concentrations ( Results: Chronic hypoxia induced a significant increase (36.4%) in right ventricular (RV) systolic pressure (RVSP) in WT mice, which was not observed in CRH-ACE2KI mice. No significant differences in RVSP were observed between male and female mice in any of the groups. Conclusion: Overexpression of ACE2 in CRH cells was protective against hypoxia-induced PH. Since the majority of expression of CRH is in brain nuclei such as paraventricular nucleus of the hypothalamus (PVN) and/or central nucleus of the amygdala (CeA) these data indicate that the protective effects of ACE2 are, at least in part, centrally mediated. This contributes to the systemic nature of PH disease and that CRH neurons may play an important role in PH.

Indexed as

brain-lung axischronic hypoxiadysautonomianeuroimmune interactionneuroinflammationpulmonary hypertension

Identifiers

PMID37638323
PMCPMC10447887
OpenAlexW4385721546

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.